Ketoconazol Ratiopharm

Ketoconazole, the active ingredient in Ketoconazol Ratiopharm, is an imidazole antifungal presented as a topical formulation for skin use. It treats fungal infections such as ringworm, seborrheic dermatitis, tinea versicolor and cutaneous candidiasis in adults and children as directed.

GNH USA supplies Ketoconazol Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ketoconazole is used to treat superficial fungal infections of the skin.

Dermatophytosis (ringworm): eliminates the causative dermatophyte and clears lesions. Seborrheic dermatitis: reduces Malassezia overgrowth and improves scaling and erythema. Tinea versicolor: restores normal skin pigmentation by eradicating Malassezia species. Cutaneous candidiasis: resolves Candida‑related skin lesions and associated itching.

Ketoconazol Ratiopharm may cause local skin reactions and, rarely, systemic effects.

Common Side Effects: - Burning sensation at the application site - Itching or pruritus - Redness or erythema - Dryness of the treated skin - Stinging feeling - Mild irritation

Serious or Rare Side Effects: - Contact dermatitis with severe swelling - Generalized skin rash or urticaria - Angioedema involving face or lips - Hepatotoxicity from systemic absorption (rare) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Anaphylactic reaction requiring emergency care

Before using Ketoconazol Ratiopharm, consider the following safety measures.

Skin integrity: avoid application on broken, ulcerated or inflamed skin. Allergy: discontinue use immediately if hypersensitivity or rash develops. Pregnancy: use only if the potential benefit justifies the potential risk to the fetus. Drug interactions: avoid concurrent use with other topical antifungals unless directed by a healthcare professional. Children: follow pediatric guidance and monitor for irritation. Store at room temperature: keep in the original container, protect from moisture and light.

Ketoconazol Ratiopharm can interact with certain systemic and topical agents.

Major Interactions (Avoid): - Systemic azoles: increased systemic absorption may enhance toxicity. - Topical corticosteroids: may reduce antifungal efficacy. - Warfarin: potential increased anticoagulant effect if systemic absorption occurs.

Moderate Interactions (Monitor Closely): - Oral ketoconazole: additive risk of hepatotoxicity. - Erythromycin: possible increase in plasma levels of ketoconazole. - Rifampin: may decrease antifungal activity by inducing metabolic pathways.